Stock Analysis on Net
Stock Analysis on Net

Thermo Fisher Scientific Inc. (NYSE:TMO)

Common-Size Balance Sheet: Assets
Quarterly Data

Thermo Fisher Scientific Inc., common-size consolidated balance sheet: assets (quarterly data)

Microsoft Excel
Mar 30, 2024 Dec 31, 2023 Sep 30, 2023 Jul 1, 2023 Apr 1, 2023 Dec 31, 2022 Oct 1, 2022 Jul 2, 2022 Apr 2, 2022 Dec 31, 2021 Oct 2, 2021 Jul 3, 2021 Apr 3, 2021 Dec 31, 2020 Sep 26, 2020 Jun 27, 2020 Mar 28, 2020 Dec 31, 2019 Sep 28, 2019 Jun 29, 2019 Mar 30, 2019
Cash and cash equivalents 5.66 8.18 6.34 3.33 3.68 8.77 3.22 2.08 2.97 4.71 16.34 10.37 8.47 14.95 11.77 9.45 5.08 4.11 2.24 3.95 1.99
Short-term investments 1.80 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts receivable, less allowances 8.17 8.33 8.62 8.52 8.37 8.35 8.47 8.55 8.51 8.39 7.55 8.09 8.42 8.31 8.10 7.27 7.68 7.45 7.73 7.12 7.47
Inventories 5.29 5.15 5.57 6.01 5.98 5.80 6.32 6.26 5.91 5.31 6.67 6.83 6.59 5.83 5.98 5.92 5.89 5.77 5.83 5.54 5.62
Contract assets, net 1.46 1.46 1.51 1.56 1.45 1.35 1.38 1.27 1.15 1.02 1.10 1.19 1.19 1.06 1.09 1.11 1.12 1.03 0.00 0.00 0.00
Other current assets 1.96 1.78 1.75 1.83 1.87 1.69 1.92 1.82 1.71 1.72 1.94 1.97 2.16 1.64 1.53 1.86 1.94 2.01 2.73 2.75 2.80
Current assets 24.35% 24.91% 23.79% 21.25% 21.35% 25.97% 21.32% 19.98% 20.24% 21.14% 33.59% 28.45% 26.82% 31.80% 28.46% 25.61% 21.70% 20.37% 18.53% 19.36% 17.88%
Property, plant and equipment, net 9.60 9.57 9.44 9.87 9.88 9.55 9.53 9.42 9.11 8.76 9.58 9.69 9.30 8.56 8.09 7.93 8.07 8.13 7.79 7.58 7.54
Acquisition-related intangible assets, net 16.53 16.89 17.61 18.53 18.99 17.95 19.68 20.51 20.89 21.14 16.21 18.30 19.46 18.37 20.09 21.38 23.08 24.00 25.23 25.64 26.06
Other assets 4.37 4.05 4.25 4.37 4.21 4.12 4.76 4.75 4.77 4.88 4.06 3.82 3.73 3.56 3.11 3.35 3.50 3.44 3.28 2.99 3.13
Goodwill 45.15 44.59 44.90 45.98 45.57 42.40 44.72 45.34 44.98 44.07 36.56 39.74 40.68 37.71 40.25 41.73 43.64 44.05 45.17 44.43 45.39
Long-term assets 75.65% 75.09% 76.21% 78.75% 78.65% 74.03% 78.68% 80.02% 79.76% 78.86% 66.41% 71.55% 73.18% 68.20% 71.54% 74.39% 78.30% 79.63% 81.47% 80.64% 82.12%
Total assets 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (reporting date: 2024-03-30), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-07-01), 10-Q (reporting date: 2023-04-01), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-10-01), 10-Q (reporting date: 2022-07-02), 10-Q (reporting date: 2022-04-02), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-10-02), 10-Q (reporting date: 2021-07-03), 10-Q (reporting date: 2021-04-03), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-26), 10-Q (reporting date: 2020-06-27), 10-Q (reporting date: 2020-03-28), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-28), 10-Q (reporting date: 2019-06-29), 10-Q (reporting date: 2019-03-30).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Thermo Fisher Scientific Inc. current assets as a percentage of total assets increased from Q3 2023 to Q4 2023 but then slightly decreased from Q4 2023 to Q1 2024 not reaching Q3 2023 level.
Property, plant and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Thermo Fisher Scientific Inc. property, plant and equipment, net as a percentage of total assets increased from Q3 2023 to Q4 2023 and from Q4 2023 to Q1 2024.
Long-term assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Thermo Fisher Scientific Inc. long-term assets as a percentage of total assets decreased from Q3 2023 to Q4 2023 but then increased from Q4 2023 to Q1 2024 not reaching Q3 2023 level.